Suchergebnisse - "van Eijck, Casper H J"

PubPharm (14)

1

FOLFIRINOX chemotherapy modulates the peripheral immune landscape in pancreatic cancer : Implications for combination therapies and early response prediction

enthalten in: European journal of cancer (Oxford, England : 1990) | 2024

von van Eijck, C. | Strijk, G. | Vietsch, E. | +7

2

A liquid biomarker signature of inflammatory proteins accurately predicts early pancreatic cancer progression during FOLFIRINOX chemotherapy

enthalten in: Neoplasia (New York, N.Y.) | 2024

von van Eijck, C. | Sabroso-Lasa, S. | Strijk, G. | +5

3

A multigene circulating biomarker to predict the lack of FOLFIRINOX response after a single cycle in patients with pancreatic ductal adenocarcinoma

enthalten in: European journal of cancer (Oxford, England : 1990) | 2023

von van Eijck, C. | de Koning, W. | van der Sijde, F. | +6

4

Neoadjuvant Radiotherapy After (m)FOLFIRINOX for Borderline Resectable Pancreatic Adenocarcinoma : A TAPS Consortium Study

enthalten in: Journal of the National Comprehensive Cancer Network : JNCCN | 2022

von Janssen, Q. | van Dam, J. | Prakash, L. | +15

5

FOLFIRINOX as Initial Treatment for Localized Pancreatic Adenocarcinoma : A Retrospective Analysis by the Trans-Atlantic Pancreatic Surgery Consortium

enthalten in: Journal of the National Cancer Institute | 2022

von Janssen, Q. | van Dam, J. | Doppenberg, D. | +12

CommentIn: J Natl Cancer Inst. 2022 May 9;114(5):641-642. - PMID 35157049

6

Quality of life of locally advanced pancreatic cancer patients after FOLFIRINOX treatment

enthalten in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer | 2022

von van der Sijde, F. | Schafthuizen, L. | van 't Land, F. | +4

7

Serum cytokine levels are associated with tumor progression during FOLFIRINOX chemotherapy and overall survival in pancreatic cancer patients

enthalten in: Frontiers in immunology | 2022

von van der Sijde, F. | Dik, W. | Mustafa, D. | +14

8

Added Value of Radiotherapy Following Neoadjuvant FOLFIRINOX for Resectable and Borderline Resectable Pancreatic Cancer : A Systematic Review and Meta-Analysis

enthalten in: Annals of surgical oncology | 2021

von Janssen, Q. | van Dam, J. | Kivits, I. | +11

9

Organoids Derived from Neoadjuvant FOLFIRINOX Patients Recapitulate Therapy Resistance in Pancreatic Ductal Adenocarcinoma

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2021

von Farshadi, E. | Chang, J. | Sampadi, B. | +7

10

Serum miR-373-3p and miR-194-5p Are Associated with Early Tumor Progression during FOLFIRINOX Treatment in Pancreatic Cancer Patients : A Prospective Multicenter Study

enthalten in: International journal of molecular sciences | 2021

von van der Sijde, F. | Homs, M. | van Bekkum, M. | +15